Intracranial stenosis is the narrowing of the blood arteries or the formation of blood clots as a result of the accumulation of lipids, plaque, and other substances in the blood vessels. Intracranial Stents Market illness is characterized by a stroke that affects either an intracranial artery or the carotid artery in the neck. In this situation, stents function as permanent implant that unblocks the blocked arteries, allowing blood to flow to the brain. Patients who have experienced a stroke or transient ischemic attack may benefit from angioplasty (the use of a balloon catheter) and stent insertion (TIA). It is challenging to use these stents in the arteries of the brain because they were created for use in the heart.
However, the incidence of
artery narrowing recurring can be reduced with the introduction of new
self-expanding brain stents. In the case of wide-neck cerebral aneurysms, the
Acclino microstent from Acandis GmbH exhibits a promising rate of immediate and
mid-term full aneurysm occlusion with a satisfactory safety profile.
The
rise in Intracranial
Stents Market use
for the treatment of intracranial stenosis and the management of stroke due to
the rising prevalence of high blood pressure, as well as the rising demand for
minimally invasive intracranial surgery, are the factors driving the global
intracranial stent market during the forecasted period. The expansion of the
elderly population and the development of the healthcare sector, along with
increased government spending to build out healthcare infrastructure and the
rising adoption of technologically advanced intracranial stents, are also
contributing to the growth of the global Intracranial Stents Market.
Key players
Medtronic Plc, Balt
Extrusion S.A., MicroPort Scientific Corporation, Abbott Laboratories, Stryker
Corporation, Admedes Schuessler GmbH, Cardiatis, S.A, DePuy Synthes, Acandis
GmbH, and Penumbra, Inc. are significant market participants in the
intracranial stents industry.
Comments
Post a Comment